Check Out These Two Dividend Stocks Dan Loeb Holds For Steady Gains
Dan Loeb’s Third Point Management has earned annualized returns of 15.7% since its inception in 1995 through December 2016.
Check Out These 3 Blue Chip Dividend Stocks Bill Gates Uses To Mitigate Recession Risk
Bill Gates the co-founder of Microsoft has been actively involved in investing for change to lessen the impact of climate change. Gates is doing this by investing in companies such as Quantumscape (NYSE: QS), whose objective is to develop solid state batteries for electric vehicles.
Carl Icahn Likes These 2 High Yielders: 2 Energy Suppliers That May Get ‘The Lift’
When Carl Icahn buys shares of stock, it's what is known as the “Icahn lift." This refers to the impact that the so-called "corporate raider" has on purchasing shares of an underlying company.
He Bet Against Subprime Mortgages, Now John Paulson Is Bullish On Gold Stocks: 2 Gold Mining High Yielders He Owns
A Wall Street investor, who's his claim to fame was betting against subprime mortgages by using credit default swaps, appears to be bullish on equities in the gold sector.
Goldman Sachs Is Bearish On Equities: What Is TINA — And How’d We End Up At TARA?
Along with other large banks, Goldman Sachs Group Inc (NYSE: GS) is becoming less bullish on stocks in the near term, saying that markets have not yet factored in the possibility of a worldwide recession.
Find Out Why This Bear Thinks The S&P 500 Is Headed To 3,000; What He’s Buying During The Downturn
On Monday, Dan Niles, the founder of the Satori Fund, joined CNBC’s ‘Squawk Box’ to discuss the current condition of the market.
Watch Out! This Activist Investor May Put Pressure On These 3 High-Yielding Stocks
Trian Partners was founded in 2005 by activist investor Nelson Peltz, who has a history of buying up shares, securing board seats and orchestrating M&A deals.
Founder Of World’s Largest Hedge Fund Rails Against Fed, Predicts 20% Stock Plummet
The Federal Reserve's raising of interest rates could bring the economy "down," according to billionaire Ray Dalio.
In a recent LinkedIn post, the Bridgewater Associates founder said increasing interest rates to about 4.5% — meant to offset inflation — will cause stock prices to plummet by 20%.
Conformis Shares Shoot Higher Following FDA Clearance For Actera Hip System
Conformis (NASDAQ: CFMS) has received 510(k) clearance from the U.S. Food and Drug Administration for its Actera Hip System.
Actera utilizes an advanced tri-taper femur stem design that facilitates direct anterior approach total hip arthroplasties, and provides an additional stem option to orthopedic surgeons.
Syros Shares Soar As FDA Grants Orphan Drug Status To Pancreatic Cancer Candidate
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Syros Pharmaceuticals (NASDAQ: SYRS) lead candidate SY-5609 for the treatment of pancreatic cancer.